Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amulet Pharmaceuticals
company
About
Amulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $1.70M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Close
Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.70M
Amulet Pharmaceuticals has raised a total of
$1.70M
in funding over 2 rounds. Their latest funding was raised on
Mar 5, 2007 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 5, 2007 | Series A | $1.70M | 1 |
Wilmington Investor Network
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Amulet Pharmaceuticals is funded by 1 investors.
Wilmington Investor Network
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Wilmington Investor Network
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
